Home GSK sees drop in earnings after asset swap with Novartis
 

Keywords :   


GSK sees drop in earnings after asset swap with Novartis

2015-07-29 15:23:08| Biotech - Topix.net

Britain-based drugmaker GlaxoSmithKline has reported a drop in earnings in the first full quarter since its deal to swap some assets with Swiss rival Novartis. Second-quarter net income fell to 149 million pounds from 654 million pounds a year earlier.

Tags: with drop asset sees

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
28.09Atlantic Tropical Weather Outlook
28.09Eastern North Pacific Tropical Weather Outlook
27.09Washington Corner | September 2024
27.09Hurricane Isaac Graphics
27.09Remnants of John Graphics
27.09Remnants of John Forecast Discussion Number 20
27.09Remnants of John Wind Speed Probabilities Number 20
27.09Remnants of John Public Advisory Number 20
More »